How Taiwan’s Developing More Equitable Cancer Treatment
A team at ITRI (Taiwan’s Industrial Technology Research Institute) is developing a new generation of immunotherapy that could reshape oncology. The aim is to go beyond killing cancer through radiation and chemotherapy and instead reactivate the body’s natural killer cells to attack cancer cells more effectively. ITRI’s experts guide us through how AI is driving down research timelines and costs to make next generation cancer treatment more affordable – and why Taiwan’s government is prioritizing domestic medical innovation in a post-Covid world.
